Arcus Biosciences (RCUS) Assets (2017 - 2026)
Arcus Biosciences' Assets was $924 million in Q2 2026, down 14.0% from $1.08 billion a year earlier and down 7.3% from the prior quarter.
Powered by 
Analysis
Arcus Biosciences (RCUS) Assets (2017 - 2026) Analysis & Trends
At the end of FY2025, Assets at Arcus Biosciences came in at $1.14 billion, down 1.0% from FY2024.
- Assets shows a five-year compound annual growth rate of 8.1% (FY2020 to FY2025).
- In earlier years, Assets was $1.15 billion in FY2024 (+5.0%), $1.1 billion in FY2023 (-18.6%), $1.35 billion in FY2022 (-15.5%) and $1.59 billion in FY2021 (+106.1%).
- The Q2 2026 figure marks the lowest quarterly Assets since Q3 2021.
- Compared with a year earlier, Assets has declined for six straight quarters, with an average decline of 7.6% over the last eight quarters.
- The best year-over-year quarter for Assets over five years was Q4 2021 (growth of 106.1%); the worst was Q3 2025 (a decline of 22.2%).
- Per Business Quant data, RCUS's Assets in the three quarters before Q2 2026 was $997 million (Q1 2026), $1.14 billion (Q4 2025) and $974 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Arcus Biosciences | 3.18 Bn | -157.19 Mn | - | 924.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 924.00 Mn |
| Mar 31, 2026 | 997.00 Mn |
| Dec 31, 2025 | 1.14 Bn |
| Sep 30, 2025 | 974.00 Mn |
| Jun 30, 2025 | 1.08 Bn |
| Mar 31, 2025 | 1.16 Bn |
| Dec 31, 2024 | 1.15 Bn |
| Sep 30, 2024 | 1.25 Bn |
| Jun 30, 2024 | 1.19 Bn |
| Mar 31, 2024 | 1.29 Bn |
| Dec 31, 2023 | 1.10 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.22 Bn |
| Mar 31, 2023 | 1.25 Bn |
| Dec 31, 2022 | 1.35 Bn |
| Sep 30, 2022 | 1.39 Bn |
| Jun 30, 2022 | 1.48 Bn |
| Mar 31, 2022 | 1.54 Bn |
| Dec 31, 2021 | 1.59 Bn |
| Sep 30, 2021 | 839.29 Mn |
API Access
Arcus Biosciences Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=RCUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "RCUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=RCUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();